Chicago Equity Partners’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Chicago Equity Partners’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$333K	Sell	5,890 -7,296	-55%	-$416K	0.03%	515
2019 Q4	$751K	Sell	13,186 -7,385	-36%	-$392K	0.04%	537
2019 Q3	$1.1M	Buy	20,571 +7,965	+63%	+$464K	0.05%	467
2019 Q2	$753K	Sell	12,606 -165	-1%	-$10.4K	0.03%	604
2019 Q1	$796K	Buy	+12,771	New	+$845K	0.03%	568
2017 Q4	–	Sell	-13,835	Closed	-$644K	–	859
2017 Q3	$644K	Buy	13,835 +610	+5%	+$29.2K	0.02%	585
2017 Q2	$655K	Buy	13,225 +110	+0.8%	+$5.76K	0.02%	588
2017 Q1	$719K	Buy	13,115 +3,565	+37%	+$189K	0.02%	523
2016 Q4	$532K	Buy	+9,550	New	+$459K	0.01%	585

Other funds holding BSTC

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Chicago Equity Partners's BSTC Position: Q1 2020 in Review

Chicago Equity Partners reduced its BioSpecifics Technologies Corp. (BSTC) stake by 55% in Q1 2020, selling an estimated $416K and leaving 5,890 shares worth $333K. The position accounts for 0.03% of the portfolio, ranked #515.

Chicago Equity Partners first reported a position in BSTC in Q4 2016 and has held it in 9 quarters since. The position peaked at $1.1M in Q3 2019. 113 funds tracked by Wall St. Rank hold BSTC as of Q1 2020.

Chicago Equity Partners held 5,890 shares of BioSpecifics Technologies Corp. worth $333K as of Q1 2020.
Chicago Equity Partners sold 7,296 BioSpecifics Technologies Corp. shares in Q1 2020, an estimated $416K.
BioSpecifics Technologies Corp. made up 0.03% of Chicago Equity Partners's portfolio in Q1 2020, its #515 holding.
Chicago Equity Partners first reported a position in BioSpecifics Technologies Corp. in Q4 2016 and has held it in 9 quarters since.
Chicago Equity Partners's BioSpecifics Technologies Corp. position peaked at $1.1M in Q3 2019.
113 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q1 2020.

Based on Chicago Equity Partners's 13F filing for Q1 2020, filed 6 May 2020.